Biodexa Pharmaceuticals Plc (BDRX)
1.25
-0.07
(-5.30%)
USD |
NASDAQ |
May 02, 13:19
Biodexa Pharmaceuticals Revenue (TTM): 0.4761M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4761M |
| June 30, 2023 | 0.6446M |
| December 31, 2022 | 0.86M |
| June 30, 2022 | 0.827M |
| December 31, 2021 | 0.7991M |
| June 30, 2021 | 0.7914M |
| December 31, 2020 | 0.4392M |
| June 30, 2020 | 0.4943M |
| December 31, 2019 | 0.8669M |
| June 30, 2019 | 2.368M |
| Date | Value |
|---|---|
| December 31, 2018 | 2.535M |
| June 30, 2018 | 1.433M |
| December 31, 2017 | 1.290M |
| June 30, 2017 | -1.418M |
| December 31, 2016 | 2.217M |
| June 30, 2016 | 5.833M |
| December 31, 2015 | 2.090M |
| June 30, 2015 | 0.6877M |
| December 31, 2014 | 0.252M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.4392M
Minimum
Dec 2020
2.368M
Maximum
Jun 2019
0.8567M
Average
0.7953M
Median
Revenue (TTM) Benchmarks
| Adaptimmune Therapeutics PLC | 60.28M |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | -- |
| Mereo BioPharma Group PLC | 10.00M |
| Bicycle Therapeutics PLC | 26.98M |